TREA

97975242 - ALLISON INSTITUTE

Follow

Information

  • Trademark
  • 97975242
  • Serial Number
    97975242
  • Filing Date
    March 25, 2022
    2 years ago
  • Transaction Date
    April 12, 2024
    a month ago
  • Status Date
    April 11, 2024
    a month ago
  • Published for Opposition Date
    February 21, 2023
    a year ago
  • Location Date
    April 18, 2023
    a year ago
  • Status Code
    731
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    GLUECK, CHRISTOPHER N
  • Attorney Name
    Robin Lightner Maisashvili
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ALLISON INSTITUTE
Case File Statements
  • GS0361: Charitable fundraising services
  • GS0351: Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
  • GS0451: Providing patient advocate services in the treatment of diseases and disorders utilizing immunotherapy
  • GS0441: Medical services; Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Medical services relating to cancer; Dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic testing, monitoring and reporting services; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical services, namely, treatment in the field of oncology and related health problems and diseases; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment; medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions
  • D10000: "INSTITUTE"
  • GS0421: Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the field of immunobiology, immunotherapy, antibodies, and oncology; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; Pharmaceutical research services; Pharmaceutical research services relating to cancer
Case File Event Statements
  • 4/12/2024 - a month ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/11/2024 - a month ago
    26 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 4/11/2024 - a month ago
    25 - SOU EXTENSION 2 FILED Type: EXT2
  • 4/11/2024 - a month ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/13/2023 - 7 months ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/11/2023 - 7 months ago
    22 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/11/2023 - 7 months ago
    21 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/11/2023 - 7 months ago
    20 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/18/2023 - a year ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/21/2023 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/21/2023 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/1/2023 - a year ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/17/2023 - a year ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/11/2023 - a year ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/11/2023 - a year ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/11/2023 - a year ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/11/2023 - a year ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/12/2022 - a year ago
    10 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 11/1/2022 - a year ago
    9 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 12/5/2022 - a year ago
    8 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 11/1/2022 - a year ago
    7 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 8/29/2022 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/29/2022 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/29/2022 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/25/2022 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/30/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/29/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP